TBPH
Theravance Biopharma Inc

1,001
Mkt Cap
$719.16M
Volume
220,285.00
52W High
$15.15
52W Low
$7.90
PE Ratio
61.05
TBPH Fundamentals
Price
$14.28
Prev Close
$14.14
Open
$14.25
50D MA
$14.01
Beta
0.55
Avg. Volume
453,468.38
EPS (Annual)
-$1.16
P/B
3.20
Rev/Employee
$663,721.65
Loading...
Loading...
Theravance Biopharma, Inc. is a biopharmaceutical company, which engages in the discovery, research, development, and commercialization of respiratory medicines. It operates through the U.S. and Europe geographical segments. Its products include telavancin under the VIBATIV brand, revefenacin under the TD 4208 brand, and neprilysin. The company was founded in July 2013 and is headquartered in George Town, Cayman Islands.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
97

Frequently Asked Questions

What is Market Cap of Theravance Biopharma Inc?
What is the 52-week high for Theravance Biopharma Inc?
What is the 52-week low for Theravance Biopharma Inc?
What is Theravance Biopharma Inc stock price today?
What was Theravance Biopharma Inc stock price yesterday?
What is the PE ratio of Theravance Biopharma Inc?
What is the Price-to-Book ratio of Theravance Biopharma Inc?
What is the 50-day moving average of Theravance Biopharma Inc?
How many employess does Theravance Biopharma Inc has?

Latest TBPH News

View

Advertisement|Remove ads.

Advertisement|Remove ads.